| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 116.16B | — |
| Operating expense | — | — |
| Net income | 24.15B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ON40.MU returned +43.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +10.2% |
| 1 year | +43.1% |
| All-time high | €9.25 (Jul 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ON40.MU would be worth today ›Yes. Ono Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.07 per share on Mar 31, 2026. The dividend yield is 3.43%.
Ono Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Ono Pharmaceutical Co., Ltd. has a market cap of 5.98B EUR, based on the latest quote.
